N/A N=120 Influence of Acupuncture in the Placental Expulsion Time
Placental Expulsion Time
Primary: The Principal Outcome of the Study is the Placental Expulsion Time. — 15.21; 5.23 minutes — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=29 Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial
Postpartum Period
Primary: Mirena in Place — 10; 3 participants
Phase 4 N=29 A Pilot Study of Early Postpartum Intrauterine Contraception
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
N/A N=404 Early vs. Interval Postpartum IUD Insertion
Contraception
Primary: Proportion of Participants With an IUD Expulsion (Complete) at 6 Months — 0; 3 Participants
N/A N=123 Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
N/A N=251 Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
Placenta, Retained · Postpartum Hemorrhage
Primary: Placental Retention Rate — 26; 8; 24 participants — p=0.05
N/A N=102 Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery
Contraception
Primary: IUD Usage Rate at 6 Months — 43; 39 participants
N/A N=120 Insertion of an Intrauterine Device (IUD) After Medical Abortion
Intrauterine Device Expulsion · Medical Abortion · Induced Abortion
Primary: Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion. — 4 percentage of participants
Phase 4 N=59 Immediate vs. Delayed Postpartum Etonogestrel Implant
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants
Phase 4 N=90 Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
N/A N=142 Umbilical Cord Clamping: What Are the Benefits
Delayed Cord Clamping
Primary: Change of Heart Rate After Delayed Umbilical Clamping — 164; 157; 163; 155 bpm
N/A N=106 Accuracy of Blood Loss Estimation After Vaginal Delivery
Postpartum Hemorrhage
Primary: Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters. — -20.8; -41.7; -53.5; -96.0 milliliters — p=<0.05
N/A N=150 Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
Postpartum Period
Primary: Bleeding Patterns — 15; 18; 13; 7 days
N/A N=74 Cord Clamping Level Above or Below Mother's Perineum
Pre-term Birth · Delayed Cord Clamping
Primary: Hematocrit Level — 51.5; 52.6 % of blood composed of red blood cells — p=0.572
N/A N=21 Delayed Cord Clamping for Congenital Diaphragmatic Hernia
Congenital Diaphragmatic Hernia
Primary: Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping — 17 Participants
N/A N=112 Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
Phase 4 N=50 LNG-IUS at 2 Weeks Postpartum
Contraception · Malposition of Intrauterine Contraceptive Device
Primary: Number of Participants Who Would Recommend the LNG-IUS to a Friend at 6-months Postpartum. — 40 Participants
Phase 3 N=95 Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Postpartum Contraception · Family Planning
Primary: Time to Lactogenesis Stage II [Questionnaire] — 65; 67.5 hours
N/A N=180 Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation
Second Trimester Abortion
Primary: D&E Procedure Time — 7.35; 7.55 minutes
Phase 4 N=30 Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Abortion, Second Trimester · PPROM · Rupture, Spontaneous
Primary: Delivery Within 12 Hours — 5; 5 Participants
N/A N=400 Timing of Antibiotic Prophylaxis for Cesarean Deliveries
Infection
Primary: Endometritis and Wound Infection — 6; 4 patients infected
Phase 4 N=88 'Levonorgestrel IUD Insertion After D&E Procedure
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
Phase 4 N=178 Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation
Abortion
Primary: Procedure Duration — 6.8; 7.2 minutes
Phase 4 N=69 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
Phase 4 N=150 Breastfeeding Etonogestrel Implant Study
Contraception
Primary: Number of Participants With Continuation of Breastfeeding at 8 Weeks Postpartum — 54; 45; 48; 43 Participants
N/A N=204 Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours
Induction of Labor Affected Fetus / Newborn
Primary: Time From Foley Bulb Placement to Time of Delivery. — 24.2; 24.57 hr — p=0.8
N/A N=166 Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
Abortion · Dilation and Evacuation · Hemorrhage
Primary: Rate at Which Providers Intervene to Control Blood Loss During D&E Procedures. — 13; 6 Participants
Phase 4 N=7 Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section
Contraception
Primary: Successful Retention of IUD — 7 participants
Phase 4 N=284 Uterotonic Prophylaxis Trial
Hemorrhage
Primary: Number of Participants With Excessive Bleeding as Determined by the Composite Outcome Criteria — 78; 75 Participants — p=0.5
Phase 4 N=108 Pitocin or Oral Misoprostol for PROM IOL
PROM
Primary: Time From Induction of Labor (IOL) to Delivery — 18.1; 14.9 Hours